Preferred Stock OfferingsBy Preferred Stock Channel Staff, updated Sun, August 14, 9:19 PM
|This Slide: #375 of 582|
Slide #375. Dynegy — Preferred Stock Offering
Date of Pricing:
Price Per Share:
Preferred Stock Offering Details:
Dynegy Inc. (NYSE:DYN) is commencing concurrent underwritten public offerings of 22,500,000 shares of common stock and 4,000,000 shares of mandatory convertible preferred stock with a liquidation preference of $100.00 per share. In addition, Dynegy expects to grant the underwriters in each respective offering an option to purchase up to 3,375,000 additional shares of common stock and up to 600,000 additional shares of mandatory convertible preferred stock. The common stock offering and the mandatory convertible preferred stock offering are separate public offerings by means of separate prospectus supplements and are not contingent on one another.
Dyne Therapeutics is a muscle disease company focused on developing therapeutics for people living with genetically driven diseases. Co. is developing the following product candidates: DYNE-101, to address the genetic basis of myotonic dystrophy type 1 by targeting the toxic nuclear DMPK RNA that causes the disease; DYNE-251 for patients with mutations amenable to skipping Exon 51, to be followed by the development of therapeutics for patients with mutations amenable to skipping other exons, including Exon 53, 45 and 44; and DYNE-301 to address the genetic basis of facioscapulohumeral dystrophy by reducing DUX4 expression in muscle tissue.
Open the DYN Page at Preferred Stock Channel »
Free DYN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Strong Buy (3.83 out of 4)
(ranked higher than approx. 68% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com